Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | NAAA | Q02083 | 3/20 | 0.55 |
| ▸ | FAAH | O00519 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | GNAI3 | P08754 | 4/20 | 0.43 |
| ▸ | GNAI1 | P63096 | 4/20 | 0.43 |
| ▸ | GNAO1 | P09471 | 3/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | MITF | O75030 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9576425 | 1.00 | LMNA (0.59) | LMNAL3MBTL1MEN1KMT2ATDP1 | |
| SCHEMBL8382827 | 1.00 | LMNA (0.59) | LMNAL3MBTL1MEN1KMT2ATDP1 | |
| SCHEMBL8381990 | 1.00 | LMNA (0.59) | LMNAL3MBTL1MEN1KMT2ATDP1 | |
| SCHEMBL8378626 | 1.00 | LMNA (0.59) | LMNAL3MBTL1MEN1KMT2ATDP1 | |
| SCHEMBL9576378 | 1.00 | LMNA (0.59) | LMNAL3MBTL1MEN1KMT2ATDP1 | |
| SCHEMBL4141304 | 1.00 | LMNA (0.59) | LMNAL3MBTL1MEN1KMT2ATDP1 | |
| SCHEMBL9576392 | 1.00 | LMNA (0.59) | LMNAL3MBTL1MEN1KMT2ATDP1 | |
| SCHEMBL8377436 | 1.00 | LMNA (0.59) | LMNAL3MBTL1MEN1KMT2ATDP1 | |
| SCHEMBL176310 | 1.00 | LMNA (0.59) | LMNAL3MBTL1MEN1KMT2ATDP1 | |
| SCHEMBL6659196 | 1.00 | LMNA (0.59) | LMNAL3MBTL1MEN1KMT2ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7572761-B2 | Simultaneously, by laundering with an anionic and/or nonionic surfactants, and an N-alkoxypropyl-1,3-propylenediamine compound as softener, such as those known as tradename Adogen | EVONIK DEGUSSA GMBH (DE) | 2009-08-11 | — | — | US | disclosed |
| EP-1841850-A1 | PERFUME DELIVERY SYSTEM | Degussa GmbH (DE) | 2007-10-10 | — | — | EP | disclosed |
| EP-1828365-A1 | PERFUME DELIVERY SYSTEM | Degussa GmbH (DE) | 2007-09-05 | — | — | EP | disclosed |
| WO-2007054417-A1 | PROCESS FOR CLEANING AND SOFTENING FABRICS | EVONIK DEGUSSA GMBH (DE) | 2007-05-18 | — | — | WO | disclosed |
| US-20070111925-A1 | Process for cleaning and softening fabrics | GOLDSCHMIDT CHEMICAL CORPORATION (US) | 2007-05-17 | — | — | US | disclosed |
| WO-2006079089-A1 | PERFUME DELIVERY SYSTEM | DEGUSSA GMBH (DE) | 2006-07-27 | — | — | WO | disclosed |
| US-20060165740-A1 | Perfume delivery system | GOLDSCHMIDT CHEMICAL CORPORATION (US) | 2006-07-27 | — | — | US | disclosed |
| US-20060160711-A1 | Perfume delivery system | GOLDSCHMIDT CHEMICAL CORPORATION (US) | 2006-07-20 | — | — | US | disclosed |
| WO-2006069061-A1 | PERFUME DELIVERY SYSTEM | DEGUSSA GMBH (DE) | 2006-06-29 | — | — | WO | disclosed |
| EP-0268218-B1 | PENETRATION ENHANCERS FOR TRANSDERMAL DELIVERY OF SYSTEMIC AGENTS | WHITBY RESEARCH, Inc. (US) | 1992-05-06 | — | — | EP | disclosed |
| US-4886783-A | Penetration enhancers for transdermal delivery of systemic agents | NELSON RESEARCH & DEVELOPMENT CO. (US) | 1989-12-12 | — | — | US | disclosed |
| EP-0268218-A2 | Penetration enhancers for transdermal delivery of systemic agents | WHITBY RESEARCH, Inc. (US) | 1988-05-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060165740-A1 | Perfume delivery system | CUTA, PEF1, PIGS | LMNA 3112/4885L3MBTL1 3197/4885MEN1 4019/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.